SurModics
SRDX
$32.81
Share price
27.53%
Change (1 day)
42.73%
Change (1 year)
Categories
SurModics (SRDX) - Cash on Hand
Cash on Hand as of December 2023 : $35.17 M
According to SurModics's latest financial reports the company has $35.17 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
SurModics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-09-30 | $45.35 M | 138.72% |
| 2022-09-30 | $18.99 M | -51.12% |
| 2021-09-30 | $38.87 M | -36.38% |
| 2020-09-30 | $61.09 M | 10.5% |
| 2019-09-30 | $55.29 M | -14.5% |
| 2018-09-30 | $64.67 M | 33.79% |
| 2017-09-30 | $48.33 M | 2.97% |
| 2016-09-30 | $46.94 M | -15.56% |
| 2015-09-30 | $55.58 M | 19.41% |
| 2014-09-30 | $46.55 M | 81.08% |
| 2013-09-30 | $25.7 M | -13.32% |
| 2012-09-30 | $29.65 M | -22.85% |
| 2011-09-30 | $38.44 M | 87.56% |
| 2010-09-30 | $20.49 M | -0.35% |
| 2009-09-30 | $20.56 M | -16.48% |
| 2008-09-30 | $24.62 M | -6.39% |
| 2007-09-30 | $26.3 M | -55.27% |
| 2006-09-30 | $58.81 M | 140.59% |
| 2005-09-30 | $24.44 M | 27.22% |
| 2004-09-30 | $19.21 M | 189.08% |
| 2003-09-30 | $6.64 M | -49.45% |
| 2002-09-30 | $13.14 M | -11.39% |
| 2001-09-30 | $14.84 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 65,081.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 20,594.26% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $8.07 B | 22,862.98% | 🇺🇸 USA |
 Agilent Technologies A | $1.74 B | 4,869.58% | 🇺🇸 USA |
 PerkinElmer
PKI | $2.46 B | 6,897.07% | 🇺🇸 USA |
 Alkermes ALKS | $0.77 B | 2,099.04% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.30 B | 763.18% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $80.4 M | 128.60% | 🇺🇸 USA |
 Enzo Biochem ENZ | $60.24 M | 71.27% | 🇺🇸 USA |